PURPOSE: We have previously shown that a transcriptome is found in saliva and subpanels of these mRNAs can be used as oral cancer biomarkers. In this study, we measured the presence of microRNAs (miRNA) in saliva and determined their potential as an additional set of oral cancer biomarkers. EXPERIMENTAL DESIGN: A total of 314 miRNAs were measured using reverse transcriptase-preamplification-quantitative PCR in 12 healthy controls. Degradation pattern of endogenous and exogenous saliva miRNAs were measured at room temperature over time. Selected miRNAs were validated in saliva of 50 oral squamous cell carcinoma patients and 50 healthy matched control subjects. RESULTS: We detected approximately 50 miRNAs in both the whole and supernatant saliva. Endogenous saliva miRNA degraded much slower compared with exogenous miRNA. Two miRNAs, miR-125a and miR-200a, were present in significantly lower levels (P < 0.05) in the saliva of oral squamous cell carcinoma patients than in control subjects. CONCLUSIONS: Both whole and supernatant saliva of healthy controls contained dozens of miRNAs, and similar to saliva mRNAs, these miRNAs are stable. Saliva miRNAs can be used for oral cancer detection.
PURPOSE: We have previously shown that a transcriptome is found in saliva and subpanels of these mRNAs can be used as oral cancer biomarkers. In this study, we measured the presence of microRNAs (miRNA) in saliva and determined their potential as an additional set of oral cancer biomarkers. EXPERIMENTAL DESIGN: A total of 314 miRNAs were measured using reverse transcriptase-preamplification-quantitative PCR in 12 healthy controls. Degradation pattern of endogenous and exogenous saliva miRNAs were measured at room temperature over time. Selected miRNAs were validated in saliva of 50 oral squamous cell carcinomapatients and 50 healthy matched control subjects. RESULTS: We detected approximately 50 miRNAs in both the whole and supernatant saliva. Endogenous saliva miRNA degraded much slower compared with exogenous miRNA. Two miRNAs, miR-125a and miR-200a, were present in significantly lower levels (P < 0.05) in the saliva of oral squamous cell carcinomapatients than in control subjects. CONCLUSIONS: Both whole and supernatant saliva of healthy controls contained dozens of miRNAs, and similar to saliva mRNAs, these miRNAs are stable. Saliva miRNAs can be used for oral cancer detection.
Authors: Talal El-Hefnawy; Siva Raja; Lori Kelly; William L Bigbee; John M Kirkwood; James D Luketich; Tony E Godfrey Journal: Clin Chem Date: 2004-01-12 Impact factor: 8.327
Authors: Eugene Berezikov; Victor Guryev; José van de Belt; Erno Wienholds; Ronald H A Plasterk; Edwin Cuppen Journal: Cell Date: 2005-01-14 Impact factor: 41.582
Authors: Matthew N Poy; Lena Eliasson; Jan Krutzfeldt; Satoru Kuwajima; Xiaosong Ma; Patrick E Macdonald; Sébastien Pfeffer; Thomas Tuschl; Nikolaus Rajewsky; Patrik Rorsman; Markus Stoffel Journal: Nature Date: 2004-11-11 Impact factor: 49.962
Authors: Yang Li; Maie A R St John; Xiaofeng Zhou; Yong Kim; Uttam Sinha; Richard C K Jordan; David Eisele; Elliot Abemayor; David Elashoff; No-Hee Park; David T Wong Journal: Clin Cancer Res Date: 2004-12-15 Impact factor: 12.531
Authors: Maie A R St John; Yang Li; Xiaofeng Zhou; Paul Denny; Chih-Ming Ho; Carlo Montemagno; Wenyuan Shi; Fengxia Qi; Benjamin Wu; Uttam Sinha; Richard Jordan; Lawrence Wolinsky; No-Hee Park; Honghu Liu; Elliot Abemayor; David T W Wong Journal: Arch Otolaryngol Head Neck Surg Date: 2004-08
Authors: Angela J Yoon; Shuang Wang; Jing Shen; Nicolas Robine; Elizabeth Philipone; Martin W Oster; Albert Nam; Regina M Santella Journal: Am J Transl Res Date: 2014-10-11 Impact factor: 4.060
Authors: Chih-Ko Yeh; Nicolaos J Christodoulides; Pierre N Floriano; Craig S Miller; Jeffrey L Ebersole; Shannon E Weigum; John McDevitt; Spencer W Redding Journal: Tex Dent J Date: 2010-07